Khademi Farzad, Yousefi-Avarvand Arshid, Sahebkar Amirhossein, Ghanbari Fahimeh, Vaez Hamid
Department of Microbiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Department of Microbiology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Folia Med (Plovdiv). 2018 Sep 1;60(3):339-350. doi: 10.2478/folmed-2018-0007.
Bacterial infections are the most common complications in people with HIV/AIDS. There has been no previous report on the prevalence of bacterial co-infections in Iranian HIV/AIDS-positive subjects.
To evaluate the frequency of bacterial infections in hospitalized HIV/AIDS-infected patients in Iran.
Based on PRISMA guidelines, a computerized search in related data banks using relevant keywords was performed in both Persian and English languages for articles that were published until March 10, 2017. A total of 1118 original articles were systematically reviewed to identify eligible studies on the prevalence of bacterial co-infections in HIV/AIDS-infected patients from Iran. After screening for inclusion and exclusion criteria, we extracted data from 28 eligible articles for the meta-analysis.
The overall bacterial infection rate among Iranian HIV/AIDS-positive individuals was estimated to be 48.6%. Gastrointestinal disorders (59.5%) were the most frequent bacterial infections in this group of patients followed by bacterial lymphadenopathy (38.9%), TB infection (38.2%), bacterial pneumonia (31.2%), brucellosis (26.3%), skin infections (13.3%) and sexually transmitted infections (9.7%). The prevalence of other bacterial infections including endocarditis, sepsis and Staphylococcus aureus (S. aureus) were 10%, 9.1%, and 6.9%, respectively.
The prevalence of a wide spectrum of bacterial co-infections, especially endemic infections, in Iranian HIV/AIDS-infected patients, is alarming and calls for urgent need to improve the currently applied diagnostic and preventive methods. In addition, timely treatment of these infections is pivotal to decrease the morbidity and mortality rates in HIV/AIDS-infected patients.
细菌感染是艾滋病毒/艾滋病患者最常见的并发症。此前尚无关于伊朗艾滋病毒/艾滋病阳性患者中细菌合并感染患病率的报告。
评估伊朗住院艾滋病毒/艾滋病感染患者中细菌感染的发生率。
根据PRISMA指南,使用相关关键词在波斯语和英语数据库中进行计算机检索,查找截至2017年3月10日发表的文章。对总共1118篇原始文章进行系统综述,以确定关于伊朗艾滋病毒/艾滋病感染患者中细菌合并感染患病率的符合条件的研究。在筛选纳入和排除标准后,我们从28篇符合条件的文章中提取数据进行荟萃分析。
估计伊朗艾滋病毒/艾滋病阳性个体中的总体细菌感染率为48.6%。胃肠道疾病(59.5%)是该组患者中最常见的细菌感染,其次是细菌性淋巴结病(38.9%)、结核病感染(38.2%)、细菌性肺炎(31.2%)、布鲁氏菌病(26.3%)、皮肤感染(13.3%)和性传播感染(9.7%)。包括心内膜炎、败血症和金黄色葡萄球菌感染在内的其他细菌感染的患病率分别为10%、9.1%和6.9%。
伊朗艾滋病毒/艾滋病感染患者中广泛存在细菌合并感染,尤其是地方性感染,其患病率令人担忧,迫切需要改进目前应用的诊断和预防方法。此外,及时治疗这些感染对于降低艾滋病毒/艾滋病感染患者的发病率和死亡率至关重要。